Hannah Linden
Associate Program Director, Hematology-Oncology Fellowship Program Professor · University of Washington School of Medicine
Credentials: · · · ·
History
PresentHematology-Oncology Fellowship Program Professor Fellowship · University of Washington School of Medicine
- Present
University of Washington/Fred Hutch Hematology-Oncology Fellowship · University of Washington School of Medicine
- Present
Breast Cancer Program · University of Washington School of Medicine
- 1993–1995
- 1989–1992
1981–1985
Research
Clinical Cancer Research · 2011 · 339 citations
Journal of Clinical Oncology · 2006 · First of 12 authors · Corresponding · 302 citations
Pilot Feasibility Study of an Oncology Financial Navigation Program
Journal of Oncology Practice · 2018 · 195 citations
47 papers
29 papers
- JG
18 papers
- RL
14 papers
13 papers
- GE
12 papers
8 papers
6 papers
Grants
- 2010–2021
Advanced PET/CT Imaging for Improving Clinical Trials
National Cancer Institute · U01
PI · $6M · University of Washington
- 2009–2013
Measures of Endocrine Sensitivity in Early Breast Cancer
National Cancer Institute · RC1
Contact PI · $953.7K · University of Washington
- 1999–2004
Thrombopoietin Structure/Function
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $358.8K · University of Washington
- 1997
Thrombopoietin Structure and Function
National Institute of Diabetes and Digestive and Kidney Diseases · F32
Contact PI · $70.6K · University of Washington
Clinical trials
- 2024–2028
Principal investigator · Recruiting · Phase 2
University of Washington
- 2021–2041
Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy
Principal investigator · Active not recruiting · Phase 2
University of Washington
- 2016–2018
Principal investigator · Withdrawn · Phase 2
GTx
- 2014–2019
Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast Cancer
Principal investigator · Completed · Phase 2
University of Washington